Researchers from MIT and Scripps have unveiled a promising new HIV vaccine approach that generates a powerful immune response ...

The Food and Drug Administration approved the preventative use of lenacapavir, made by Gilead Sciences, on Wednesday. Experts ...

FDA approval paves the way for the jab to roll out across the world. But with funding being slashed, will it get to the ...

FDA approves Yeztugo HIV prevention injection showing 96% efficacy in clinical trials, but $14,000 cost creates significant ...

On Wednesday, the Food and Drug Administration approved a highly effective, injectable drug to help prevent the transmission ...

Juanita Davis with Care4Me services has been educating people in the metro area about HIV prevention and she hopes the drug’s ...

Clinical trials have shown that six-monthly injections of lenacapavir are almost 100 percent protective against becoming ...

In clinical trials, researchers found Yeztugo to be highly effective as a twice-yearly form of pre-exposure prophylaxis.

The breakthrough double injection won’t be cheap in the US, although scientists argue it could (and should) be.

A drug called lenacapavir, administered in two injections a year, offers protection from HIV comparable to daily pills. One ...

The U.S. FDA approved Gilead Sciences' lenacapavir injection to prevent HIV in adults and adolescents. Marketed as Yeztugo, ...

A drug currently used to treat certain HIV infections has also, on Wednesday, received approval from the US Food and Drug ...